Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries. Over-the-counter painkillers, such as anti-inflammatory drugs, help reduce pain but do not stop unrelenting cartilage destruction. Consequently, pain related to the condition only gets worse.
Researchers funded in part by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have recently shown that magnetic bacteria are a promising vehicle for more efficiently delivering tumor-fighting drugs.
A team of researchers at Yale found that a treatment using bioadhesive nanoparticles loaded with a potent chemotherapy drug proved more effective and less toxic than conventional treatments for gynecological cancer.
A study on weaning patients in intensive care units (ICUs) has compared those who underwent prolonged weaning off mechanical ventilation (MV) with patients classified as undergoing ‘simple’ or ‘difficult’ weaning. It shows that patients who experienced ‘prolonged’ weaning from mechanical ventilation show significantly higher mortality rates. Report: Mark Nicholls
As the number of patients and people requiring care increases, exacerbating the shortage of care staff for in- and out-patients, care robots might solve the problem. For menial tasks, many devices can contribute well; however, at the complex interactive human level of care, the idea that advancing technologies could replace human caregivers to alleviate staff shortages is clearly simplistic.
IBA (Ion Beam Applications) today unveils its unique platform, 'Leading the PATh', which gathers the leading experts in the field of proton therapy all in one place. It is anticipated that 'Leading the PATh' will enable the worldwide medical community to shape the most efficient Proton Adaptive Therapy (PATh), a proton therapy process which improves the accuracy of what is considered to be the…
Changes in the genetic make-up of tissue samples can be detected quickly and easily using a new method based on nanotechnology. This report researchers from the Swiss Nanoscience Institute, the University of Basel and the University Hospital Basel in first clinical tests with genetic mutations in patients with malignant melanoma.
A small device implanted under the skin can improve breast cancer survival by catching cancer cells, slowing the development of metastatic tumors in other organs and allowing time to intervene with surgery or other therapies. These findings suggest a path for identifying metastatic cancer early and intervening to improve outcomes.
Using the results from a computerized mathematical model, Johns Hopkins researchers investigated whether they could improve heart and lung transplantation procedures by transferring patients from low-volume to high-volume transplant centers.
‘Amputation v. reconstruction’ – a vital issue – was debated by two leading surgeons during the Microsurgical Lower Limb Reconstruction session at the Advances and Controversies in Reconstructive Microsurgery (ACRM) 2016 conference, held in the United Kingdom this May. Consultant Plastic Surgeon Umraz Khan, from North Bristol NHS Trust presented a plastic surgeon’s view, while Ben…
NIBIB researchers have created a nanovaccine that could make a current approach to cancer immunotherapy more effective while also reducing side effects. The nanovaccine helps to efficiently deliver a unique DNA sequence to immune cells – a sequence derived from bacterial DNA and used to trigger an immune reaction. The nanovaccine also protects the DNA from being destroyed inside the body, where…
Multidrug resistance (MDR) is the mechanism by which many cancers develop resistance to chemotherapy drugs, resulting in minimal cell death and the expansion of drug-resistant tumors. To address the problem of resistance, researchers at the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at the National Institutes of Health (NIH) have developed nanoparticles that…
A study published in the prestigious New England Journal of Medicine offers the most in-depth assessment yet of the safety and effectiveness of a high-tech alternative to brain surgery to treat the uncontrollable shaking caused by the most common movement disorder. And the news is very good.
EPIC Alliance experts at the European Society of Cardiology (ESC) congress presented original research and real-world clinical evidence on non-responders to cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) ablation.
Fernando López Zárraga is a member of the Executive Board of the Spanish Society of Vascular and Interventional Radiology (SERVEI). In an interview with European Hospital he explains issues facing interventional radiology in Spain and why this is becoming an increasingly attractive field.
A small report in the press prompted examination of a much neglected topic. The report read ‘Heart Centre at University Hospital no longer carries out transplants’, and referred to the University Hospital Frankfurt, one of the 22 Heart Centres that perform these transplantations.
The Medtronic CoreValve Evolut R System received its CE Mark of approval this August to treat aortic stenosis in patients with an intermediate risk for undergoing conventional surgery for a valve replacement. This is a controversial indication for transcatheter aortic valve implantations (TAVI) – one that has been eagerly sought by some clinicians but resisted by others. Younger patients will…
An innovative cardiac monitoring system that delivers continuous resynchronisation to patients, has shown a 35% risk reduction of hospitalisation for heart failure (HF) patients. The finding comes from the RESPOND-CRT (cardiac resynchronisation therapy) clinical trial, which was designed to investigate the clinical efficacy and safety of device-based optimisation using the SonR cardiac…
Greater sensitivity and versatility of devices, as well as more patient-friendly implantation options, were issues outlined at the CardioStim 2016 EHRA Europace world congress on cardiac electrophysiology, held in Nice, France.
In the fast-evolving field of left atrial appendage closure a new study has delivered data that could benefit thousands of patients at risk of stroke. Led by Professor Martin Bergmann, head of Interventional Cardiology at Cardiologicum Hamburg in Germany, the EWOLUTION study was conducted to evaluate the Watchman Left Atrial Appendage (LAA) closure device from manufacturer Boston Scientific.
Cold plasma looks like the glow from the “Star Wars” blue light saber but this beam of energy, made of electrons that change polarity at micro-second or nanosecond speeds, could help bones heal faster, according to researcher from the Thomas Jefferson University.
Men with very high-risk prostate cancer, who are treated at hospitals with a high proportion of administered radical local treatment (radiotherapy or prostatectomy), only have half of the mortality risk of men who are treated at hospitals with the lowest proportion. This is according to a new study conducted by researchers at Umeå University in Sweden.
Given mounting financial pressure, a hospital needs greater efficiency in medical service structures. Staff and materials for operating theatres (OTs) account for about a third of the overall expenditure. Working closely with all other hospital departments, OT efficiency can affect a hospital’s overall efficiency and costs.
Defined processes and competencies are essential in the operating room along with the allocation of staff. Yet the OR-Barometer 2015 that is published every other year by the Frankfurt University of Applied Sciences, reveals that only 47 percent of the surveyed nursing staff in the fields of surgery and anesthesiology are satisfied with the level of organization in operating rooms. In this…
Joshua Bederson, MD, Professor and System Chair for the Department of Neurosurgery at Mount Sinai Health System, is the first neurosurgeon to use CaptiView – a microscope image injection system from Leica Microsystems that overlays critical virtual reality imaging directly onto the brain when viewed through the eyepiece, known as the ocular, during surgery.
